RCTs is a French and International Full-Service CRO with more than 35 years of experience and over 1000 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices. It is also a stable company whose staff annual renewal rate is less than 10% and the 5 main managers are associates (Frédéric Mistretta, Morgane Champiot, Audrey Lajoinie, Flavien Roux and Didier Not). IT tools (eCRF, IWRS, ePRO, eTMF, CTMS) are being constantly adapted to the constraints and evolutions of the business and regulations. These tools are developed and maintained by ClinInfo, our daughter company (http://www.clininfo.fr/). Specializations: Clinical studies, Pharmaco-epidemiology, Health economics, Medical Devices, Evaluation (CEP, CER), Consulting, Medical Writing, Clinical , eCRF, IWRS, ePRO and eTMF.
Looking for a particular RCTs employee's phone or email?
The RCTs annual revenue was $3 million in 2026.
Reg Riemer is the President of RCTs.
39 people are employed at RCTs.
RCTs is based in Lyon, Wallis and Futuna.
The NAICS codes for RCTs are [541, 54, 5417].
The SIC codes for RCTs are [873, 87].